| Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A LM Mulligan, JBJ Kwok, CS Healey, MJ Elsdon, C Eng, E Gardner, ... Nature 363 (6428), 458-460, 1993 | 2424 | 1993 |
| The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, RF Gagel, ... Jama 276 (19), 1575-1579, 1996 | 1445 | 1996 |
| Mutations of the RET proto-oncogene in Hirschsprung’s disease MA • Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S ... Nature 367, 378-380, 1994 | 1146* | 1994 |
| Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC LM Mulligan, C Eng, CS Healey, D Clayton, JBJ Kwok, E Gardner, ... Nature genetics 6 (1), 70-74, 1994 | 786 | 1994 |
| Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours C Eng, DP SmIth, LM MullIgan, MA Nagal, CS Healey, MA Ponder, ... Human molecular genetics 3 (2), 237-241, 1994 | 627 | 1994 |
| RET revisited: expanding the oncogenic portfolio LM Mulligan Nature Reviews Cancer 14 (3), 173-186, 2014 | 555 | 2014 |
| Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast A Perren, LP Weng, AH Boag, U Ziebold, K Thakore, PLM Dahia, ... The American journal of pathology 155 (4), 1253-1260, 1999 | 534 | 1999 |
| Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease T Attié, A Pelet, P Edery, C Eng, LM Mulligan, J Amiel, L Boutrand, ... Human molecular genetics 4 (8), 1381-1386, 1995 | 389 | 1995 |
| Mechanisms of p53 loss in human sarcomas. LM Mulligan, GJ Matlashewski, HJ Scrable, WK Cavenee Proceedings of the National Academy of Sciences 87 (15), 5863-5867, 1990 | 339 | 1990 |
| Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium LM Mulligan, DJ Marsh, BG Robinson, I Schuffenecker, J Zedenius, ... Journal of internal medicine 238 (4), 343-346, 1995 | 338 | 1995 |
| A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. C Eng, DP Smith, LM Mulligan, CS Healey, MJ Zvelebil, TJ Stonehouse, ... Oncogene 10 (3), 509-513, 1995 | 321 | 1995 |
| Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis JR Hansford, LM Mulligan Journal of medical genetics 37 (11), 817-827, 2000 | 314 | 2000 |
| Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene LM Mulligan, C Eng, T Attlé, S Lyonnet, DJ Marsh, VJ Hyland, ... Human Molecular Genetics 3 (12), 2163-2168, 1994 | 294 | 1994 |
| Analysis of PTEN and the 10q23 region in primary prostate carcinomas HE Feilotter, MA Nagai, AH Boag, C Eng, LM Mulligan Oncogene 16 (13), 1743-1748, 1998 | 292 | 1998 |
| Germline Dinucleotide Mutation in Codon 883 of the RETProto-Oncogene in Multiple Endocrine Neoplasia Type 2B Without Codon 918 Mutation O Gimm, DJ Marsh, SD Andrew, A Frilling, PLM Dahia, LM Mulligan, ... The Journal of Clinical Endocrinology & Metabolism 82 (11), 3902-3904, 1997 | 282 | 1997 |
| Mutations of the RET proto‐oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease C Eng, LM Mulligan Human mutation 9 (2), 97-109, 1997 | 275 | 1997 |
| Characterization of RET proto-oncogene 3'splicing variants and polyadenylation sites: a novel C-terminus for RET. SM Myers, C Eng, BA Ponder, LM Mulligan Oncogene 11 (10), 2039-2045, 1995 | 242 | 1995 |
| Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. C Eng, PA Crossey, LM Mulligan, CS Healey, C Houghton, A Prowse, ... Journal of Medical Genetics 32 (12), 934-937, 1995 | 226 | 1995 |
| Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinoma C Eng, LM Mulligan, DP Smith, CS Healey, A Frilling, F Raue, ... Clinical endocrinology 43 (1), 123-127, 1995 | 217 | 1995 |
| Heterogeneous Mutation of the RET Proto-oncogene in Subpopulations of Medullary Thyroid Carcinoma C Eng, LM Mulligan, CS Healey, C Houghton, A Frilling, F Raue, ... Cancer research 56 (9), 2167-2170, 1996 | 215 | 1996 |
Maria Aparecida NagaiProfessor Associado, Faculdade de Medicina da Universidade de São Paulo在 usp.br 的电子邮件经过验证
